Search
From Date :
To Date :
Serivce :
Query :
Keywords :
 ( Seprate With , )
Most COVID-19 patients have at least one symptom six months on: Study
More than three quarters of people hospitalized with COVID-19 still suffered from at least one symptom after six months, according to a study published on Saturday that scientists said shows the need for further investigation into lingering coronavirus effects.
Inflammation from ADT may cause fatigue in prostate cancer patients
Prostate cancer is one of the most common cancers among men in the US. For many patients, hormone therapy is a treatment option. This type of therapy, also called androgen deprivation therapy (ADT), reduces the level of testosterone and other androgens in the body. Lowering androgen levels can make prostate cancer cells grow more slowly or shrink tumors over time. However, patients receiving ADT often experience higher levels of fatigue, depression and cognitive impairment.
US doctor says beds open up only when patients die
With the number of COVID-19 hospitalizations at an all-time high in the US, medical facilities are having a hard time finding places to put new patients.
Small number of COVID patients develop severe psychotic symptoms
Almost immediately, Dr. Hisam Goueli could tell that the patient who came to his psychiatric hospital on Long Island this summer was unusual.
Most kidney patients ok with getting text reminders on care
Adults living with kidney failure are receptive to using mobile devices to help with their care, according to a new study.
First 10 days after leaving hospital carry high risk for COVID-19 patients: Study
In the first months after their COVID-19 hospital stay, patients face a high risk of ongoing health problems, trips back to the hospital, and death, a growing number of studies has shown.
Patients with noncardiac chest pain are reassured with brief education
Patients diagnosed with noncardiac chest pain are reluctant to believe they do not have heart disease. A new study shows that explaining the test results convinces patients and reduces the likelihood of future chest pain. The research is presented at EACVI—Best of Imaging 2020, a scientific congress of the European Society of Cardiology (ESC).
Chronic disease patients can't slack post virus: Expert
People with chronic illnesses who recover from COVID-19 must remain wary of its enduring effects on their bodies, a Turkish doctor warned.
Plasma from recovered patients shows little benefit in those hospitalized with COVID-19: Study
Using blood plasma from COVID-19 survivors to treat patients with severe pneumonia caused by the novel coronavirus showed little benefit, according to data released from a clinical trial in Argentina.
AI technology helps Parkinson's patients during COVID-19 pandemic
The COVID-19 pandemic is leading a Purdue University innovator to make changes as she works to provide new options for people with Parkinson's disease.
Ambitious plan to save more than nine in 10 cancer patients from death in Australia
More than 90 percent of Australians could survive their cancer diagnosis within a decade under a comprehensive new framework developed by an alliance of expert researchers, doctors, patients, health care, tech and pharmaceutical leaders.
Reducing dementia in patients with rheumatoid arthritis
The incidence of dementia in patients with rheumatoid arthritis is lower in patients receiving biologic or targeted synthetic disease modifying antirheumatic drugs (DMARDs) than in patients who receive conventional synthetic DMARDs, according to a new study.
Reducing dementia in patients with rheumatoid arthritis
The incidence of dementia in patients with rheumatoid arthritis is lower in patients receiving biologic or targeted synthetic disease modifying antirheumatic drugs (DMARDs) than in patients who receive conventional synthetic DMARDs, according to a new study.
Deliberately infecting patients with COVID-19 to speed up vaccine?
There are signs that research on a COVID-19 vaccine could be taking a new turn. But there's debate over the strategy and possible ethical concerns.
New research predicts whether rheumatoid arthritis patients will respond to treatment
A new study led by researchers at Queen Mary University of London provides potential novel biomarkers for predicting patient responsiveness to disease modifying anti-rheumatic drugs (DMARDs).

Page Generated in 0/5838 sec